- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
GMAB
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Genmab A/S · Healthcare · Biotechnology
Latest close
268.8 EUR
7.8%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 11.3% above the Trend Line and sits at 72.4% of its 52-week range. The latest completed week returned 7.8%, after a 7.4% four-week move. The latest news-sentiment score is 54/100.
Setup score
56
out of 100
Latest Close
268.8 EUR
7 Aug 2026
1W Return
7.8%
latest completed week
4W Return
7.4%
short-term follow-through
12W Return
17.5%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
5.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
7.8%
Latest completed week; four-week move 7.4%.
Indicator stack
28/76
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
54/100
14 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 11.3% above the Trend Line and sits at 72.4% of its 52-week range. The latest completed week returned 7.8%, after a 7.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 5.1x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4612-week average 0.22
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.46Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 7.4% over four weeks, 17.5% over 12 weeks, and 45.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.09Latest activity-pressure read.
Pressure change81.7%Four-week change in activity pressure.
Leadership-12.14Latest relative-leadership reading.
RS change26.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 14 relevant articles.
4 positive · 8 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-11.1%Distance below the 52-week high.
13-week volatility3.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+9.3%Week of 3 Jul.
Worst week-6.5%Week of 6 Mar.
Latest week+7.8%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains8
Flat weeks0
Modest losses9
Sharp losses4
Recent vol3.7%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew3.8% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank27 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Biotechnology
4-week rank4 / 21
Group average-4.6%
Trend breadth19.0%
Trend19.0%active weekly trend signals
MD42.9%positive activity pressure
RS4.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape49/100
Trend, activity pressure, participation, and risk combine to a 49/100 tape read.
Indicator analysis27/100Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.
Activity pressure 0.46; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 14 relevant articles.
Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Mariott International, Merck, Novo Nordisk, Okta, and More Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 268.8 EUR | 7.8% | 241.6 EUR | 243.3 EUR | 1.09 | -12.14 | 416 | Off |
| 31 Jul 2026 | 249.3 EUR | -1.2% | 242.4 EUR | 243.8 EUR | 0.97 | -16.02 | 44 | Off |
| 24 Jul 2026 | 252.3 EUR | 1.1% | 243.1 EUR | 244.3 EUR | 0.99 | -15.09 | 413 | Off |
| 17 Jul 2026 | 249.5 EUR | -0.3% | 244.1 EUR | 245.1 EUR | 0.89 | -14.99 | 88 | Off |
| 10 Jul 2026 | 250.3 EUR | 0.1% | 245.1 EUR | 245.9 EUR | 0.60 | -16.42 | 0 | Off |
| 3 Jul 2026 | 250.0 EUR | 9.3% | 245.7 EUR | 246.5 EUR | 0.33 | -17.64 | 44 | Off |
| 26 Jun 2026 | 228.8 EUR | 4.5% | 246.4 EUR | 247.1 EUR | -0.04 | -22.79 | 45 | Off |
| 19 Jun 2026 | 219.0 EUR | 1.6% | 248.0 EUR | 247.9 EUR | -0.24 | -27.60 | 0 | Off |
| 12 Jun 2026 | 215.5 EUR | -0.2% | 249.5 EUR | 248.7 EUR | -0.28 | -25.97 | 0 | Off |
| 5 Jun 2026 | 216.0 EUR | -5.1% | 251.0 EUR | 249.7 EUR | -0.35 | -24.02 | 0 | Off |
| 29 May 2026 | 227.5 EUR | -1.2% | 252.0 EUR | 250.6 EUR | -0.60 | -21.09 | 0 | Off |
| 22 May 2026 | 230.3 EUR | 0.7% | 252.7 EUR | 251.5 EUR | -0.89 | -18.06 | 0 | Off |
| 15 May 2026 | 228.8 EUR | 4.0% | 253.5 EUR | 252.4 EUR | -1.14 | -17.00 | 4 | Off |
| 8 May 2026 | 220.0 EUR | -2.7% | 255.2 EUR | 253.4 EUR | -1.29 | -20.54 | 0 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.